diprafenone has been researched along with Tachycardia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geiger, M; Kuck, KH; Kunze, KP; Schlüter, M | 1 |
Kramer, W; Kremer, P; Schlepper, M; Thormann, J | 1 |
Beermann, J; Gerckens, U; Lüderitz, B; Manz, M | 1 |
3 other study(ies) available for diprafenone and Tachycardia
Article | Year |
---|---|
Diprafenone for treatment of Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrioventricular Node; Electric Stimulation; Electrocardiography; Electroencephalography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Propafenone; Refractory Period, Electrophysiological; Tachycardia; Wolff-Parkinson-White Syndrome | 1989 |
Influence of the new class I antiarrhythmic agent diprafenone on the end-systolic pressure-volume relationship (conductance technique).
Topics: Anti-Arrhythmia Agents; Blood Pressure; Cardiac Catheterization; Catheterization; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Propafenone; Tachycardia; Vascular Resistance | 1989 |
[Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle of His; Cardiomyopathy, Dilated; Coronary Disease; Electrocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Tachycardia; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1986 |